RNA interference
0
City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver
0

City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver

Using RNA to interfere with a disease-driving protein is a proven way to address disease targets in the liver. City Therapeutics is one of the ...

admin admin October 16, 2026
READ MORE +
Show next
Som2ny Network
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart